{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:35:16Z","timestamp":1792035316994,"version":"4.4.0"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["HHSN272201300018I"],"award-info":[{"award-number":["HHSN272201300018I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["HHSN2722013000201"],"award-info":[{"award-number":["HHSN2722013000201"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["HHSN272201500002C"],"award-info":[{"award-number":["HHSN272201500002C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["UM1 AI104681"],"award-info":[{"award-number":["UM1 AI104681"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2023,10,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Fosfomycin, approved in the United States only for cystitis, is an attractive alternative for oral treatment of outpatient complicated urinary tract infections (cUTIs) as it has antimicrobial activity against most common uropathogens. The study was a multicenter, randomized, open-label pragmatic superiority clinical trial evaluating the efficacy of oral fosfomycin versus oral levofloxacin strategies in cUTIs (FOCUS study). The trial compared two strategies for initial or step-down oral therapy of cUTI without bacteremia after 0\u201348 hours of parenteral antibiotic therapy. Subjects were assigned to 3 g of fosfomycin or 750 mg (or dose adjusted for kidney function) of levofloxacin daily for 5\u20137 days. Clinical and microbiological cures were assessed at the end of therapy (EOT) and test of cure (TOC) (approximately 21 days from the start of antibiotics). The trial did not meet accrual goals; thus, the results were descriptive. Only 51 subjects were included in the microbiological intention-to-treat population. The subjects were mainly females (76%), with a mean age of 46.7 years (standard deviation [SD] = 20.8) and acute pyelonephritis (88%). At the end of therapy, clinical cure remained similar (69% and 68% for fosfomycin and levofloxacin strategies, respectively), and microbiological success was 100% for both strategies. At the test of cure, clinical cure was similar (84% and 86% in the fosfomycin and levofloxacin strategies, respectively); however, a numerically lower microbiological success was observed for fosfomycin (69% compared to 84% for levofloxacin). These limited data suggest that fosfomycin could be an oral alternative as a step-down therapy for the treatment of cUTIs (registry number NCT 03697993).<\/jats:p>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>Concerns over resistance and safety have been identified in the current treatment regimen for complicated urinary tract infections. Fosfomycin is a drug that is routinely used for the treatment of uncomplicated cystitis. This study shows that fosfomycin could be an oral alternative as step-down therapy for the treatment of complicated urinary tract infections, with a clinical cure rate comparable to levofloxacin but a lower microbiological success rate 3 weeks from start of antibiotics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/mbio.01677-23","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:01:33Z","timestamp":1694509293000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Daily fosfomycin versus levofloxacin for complicated urinary tract infections"],"prefix":"10.1128","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-7919","authenticated-orcid":false,"given":"Nadine","family":"Rouphael","sequence":"first","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Winokur","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Iowa College of Medicine , Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Keefer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Traenkner","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Drobeniuc","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9620-2525","authenticated-orcid":false,"given":"Yohei","family":"Doi","sequence":"additional","affiliation":[{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania, USA"},{"name":"Antibacterial Resistance Leadership Group, Duke University Medical Center , Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Munsiff","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Antibacterial Resistance Leadership Group, Duke University Medical Center , Durham, North Carolina, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Duke University Medical Center , Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Evans","sequence":"additional","affiliation":[{"name":"Antibacterial Resistance Leadership Group, Duke University Medical Center , Durham, North Carolina, USA"},{"name":"George Washington University , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph E.","family":"Oler","sequence":"additional","affiliation":[{"name":"The Emmes Company, LLC , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonifride","family":"Tuyishimire","sequence":"additional","affiliation":[{"name":"The Emmes Company, LLC , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, NIAID, NIH , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varduhi","family":"Ghazaryan","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, NIAID, NIH , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"Antibacterial Resistance Leadership Group, Duke University Medical Center , Durham, North Carolina, USA"},{"name":"University of California at San Francisco , San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DMID 15-0045 study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Esper","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina A.","family":"Rebolledo","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanthia","family":"Wiley","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse T.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Mehta","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen S","family":"Kraft","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun F","family":"Wang","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rody G.","family":"Bou Chaaya","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Fayad","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Bechnak","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Macenczak","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dretler","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Paine","family":"McCullough","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Jo","family":"Johnson","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Beydoun","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Saklawi","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghina","family":"Alaaeddine","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine , Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bunce","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight","family":"Hardy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Antenozzi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Moran","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Almuntazar-Harris","sequence":"additional","affiliation":[{"name":"The EMMES Company, LLC , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Wall","sequence":"additional","affiliation":[{"name":"The EMMES Company, LLC , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sumerel","sequence":"additional","affiliation":[{"name":"The EMMES Company, LLC , Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kreder","sequence":"additional","affiliation":[{"name":"University of Iowa College of Medicine , Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Takacs","sequence":"additional","affiliation":[{"name":"University of Iowa College of Medicine , Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adler","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Rochester School of Medicine and Dentistry , Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Mueller","sequence":"additional","affiliation":[{"name":"Division of Female Pelvic Medicine &amp; Reconstructive Surgery, Depart of OB\/GYN and Urology, Northwestern Medicine , Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.190"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003694"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2383-z"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1218-9"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.33073\/pjm-2019-048"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0552-0"},{"key":"e_1_3_3_9_2","article-title":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients","author":"Anonymous.","year":"2018","unstructured":"Anonymous. Dec 21, 2018. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. U.S Food & Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. Accessed","journal-title":"U.S Food & Drug Administration"},{"key":"e_1_3_3_10_2","article-title":"FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes","author":"Anonymous.","year":"2018","unstructured":"Anonymous. July 10, 2018. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. U.S Food & Drug Administration. Accessed","journal-title":"U.S Food & Drug Administration"},{"key":"e_1_3_3_11_2","article-title":"FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects","author":"Anonymous.","year":"2018","unstructured":"Anonymous. March 8, 2018. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. U.S Food &amp; Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics. Accessed","journal-title":"U.S Food &amp; Drug Administration"},{"key":"e_1_3_3_12_2","article-title":"Monurol Sachet","author":"Anonymous","year":"2007","unstructured":"Anonymous . 2007. Monurol Sachet. U.S Food & Drug Administration, July. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050717s005lbl.pdf.","journal-title":"U.S Food & Drug Administration"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70325-1"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics6040024"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000449422"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/2049936119858883"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2018.1500110"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy912"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00464-18"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.09.002"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60608-4"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_3_23_2","article-title":"Complicated urinary tract infections: Developing drugs for treatment","author":"Anonymous","year":"2018","unstructured":"Anonymous . 2018. Complicated urinary tract infections: Developing drugs for treatment. U.S Food & Drug Administration, June. https:\/\/www.fda.gov\/media\/71313\/download.","journal-title":"U.S Food & Drug Administration"},{"key":"e_1_3_3_24_2","unstructured":"Anonymous . Clinical and laboratory standards Institute IMEA. Available from: https:\/\/clsimena.org"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/318850"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw281"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/205910"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa034"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw378"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0438"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00837-08"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.06.008"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106106"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac045"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01677-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01677-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T14:28:47Z","timestamp":1723386527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mbio.01677-23"}},"subtitle":[],"editor":[{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10,31]]}},"alternative-id":["10.1128\/mbio.01677-23"],"URL":"https:\/\/doi.org\/10.1128\/mbio.01677-23","relation":{},"ISSN":["2150-7511"],"issn-type":[{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"2023-07-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01677-23"}}